Loading...

David Oh, MD

TitleCLINICAL FELLOW
SchoolUCSF School of Medicine
DepartmentMedicine
Address1600 Divisadero
San Francisco CA 94115
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard CollegeAB2000Biochemical Sciences
    Stanford University School of MedicineMD/PhD2011Medicine, Physiology
    University of California, San FranciscoResidency2014Internal Medicine
    University of California, San FranciscoFellowship2017Hematology/Oncology
    Collapse Awards and Honors
    University of California, San Francisco2015Clinical Fellow Award
    Conquer Cancer Foundation of American Society of Clinical Oncology 2016Merit Award
    University of California, San Francisco2016Molecular Pathology of Cancer T32
    Conquer Cancer Foundation of American Society of Clinical Oncology2017Young Investigator Award

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Oh D,* Cham J,* Zhang L, Fong G, Kwek SS, Klinger M, Faham M, Fong L. *co-first author. Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire. Cancer Res. 2017; 77(6):1322-1330.
    2. Oh DY, Venook AP, Fong L. On the Verge: Immunotherapy for Colorectal Carcinoma. J Natl Compr Canc Netw. 2015 Aug; 13(8):970-8. PMID: 26285242.
      View in: PubMed
    3. Ehrlich LI,* Oh DY,* Weissman IL, Lewis RS. *co-first author. Differential contribution of chemotaxis and substrate restriction to segregation of immature and mature thymocytes. Immunity. 2009; 31(6):986-98.
    4. Bhakta NR, Oh DY, Lewis RS. Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment. Nat Immunol. 2005 Feb; 6(2):143-51. PMID: 15654342.
      View in: PubMed
    5. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell. 2003 Mar 07; 112(5):659-72. PMID: 12628186.
      View in: PubMed
    6. Beresford PJ, Zhang D, Oh DY, Fan Z, Greer EL, Russo ML, Jaju M, Lieberman J. Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J Biol Chem. 2001 Nov 16; 276(46):43285-93. PMID: 11555662.
      View in: PubMed
    7. Gommerman JL,* Oh DY,* Zhou X, Tedder TF, Maurer M, Galli SJ, Carroll MC. *co-first author. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J Immunol. 2000; 165(12):6915-21.
    David's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP